☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
FDA Fast Track Designation
Genascence Corporation’s GNSC-001 Receives the US FDA’s Fast Track Designation for Treating Osteoarthritis (OA) of the Knee
November 14, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.